Bronstein, Gewirtz And Grossman, LLC Announces An Investigation Against Liquidia Technologies, Inc. (LQDA) And Encourages Shareholders To Seek Compensation For Alleged Wrongdoings

(MENAFN- PR Newswire) NEW YORK, Sept. 5, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Liquidia Technologies, Inc. ("Liquidia" or "the Company") (NASDAQ: LQDA ). Investors who purchased Liquidia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg/LQDA .

Investigation Details

On August 19, 2024, Liquidia issued a press release announcing that "the U.S. Food and Drug Administration (FDA) has granted tentative approval of YUTREPIATM (treprostinil) inhalation powder to treat adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)" but "must await the expiration of regulatory exclusivity of a competing product before final approval can be granted." On this news, Liquidia's stock price fell $4.32 per share, or 30.62%, to close at $9.79 per share on August 19, 2024.

What's Next?

If you are aware of any facts relating to this investigation or purchased Liquidia securities, you can assist this investigation by visiting the firm's site: bgandg/LQDA . You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660 .

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

MENAFN05092024003732001241ID1108642375